Company Filing History:
Years Active: 2009
Title: Michael F Dee: Innovator in Neurological Disorder Treatments
Introduction
Michael F Dee is a notable inventor based in Madison, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurological disorders.
Latest Patents
Michael F Dee holds a patent for "Indole acetic acid acyl guanidines as β-secretase inhibitors." This patent includes a series of substituted acyl guanidines of Formula (I) or a stereoisomer, or a pharmaceutically acceptable salt thereof. The compounds described in this patent inhibit the processing of amyloid precursor protein (APP) by β-secretase, specifically targeting the production of β-peptide. The disclosure is directed towards compounds that are useful in treating neurological disorders related to β-amyloid production, such as Alzheimer's disease and other conditions affected by anti-amyloid activity. He has 1 patent to his name.
Career Highlights
Michael F Dee is associated with Bristol-Myers Squibb Company, where he has been involved in groundbreaking research and development. His work focuses on innovative solutions for complex health issues, particularly in the realm of neurological disorders.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including Lorin A Thompson, III and Jianliang Shi. These collaborations have contributed to the advancement of research in the pharmaceutical industry.
Conclusion
Michael F Dee's contributions to the field of pharmaceuticals, particularly in the treatment of neurological disorders, highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in medical research and development.